Biobanking Workshop: legal experts met with scientists to share latest developments in the biobanking legislation
“Biobanking Workshop” with Rittershaus Rechtsanwaelte: latest developments in the biobanking legislation.
The BioRN Cluster together with Rittershaus Rechtsanwälte welcomed on Wednesday June 13, several “Biobankers” from Heidelberg, Tübingen and Frankfurt. Prof. Dr. Dr. Tade M. Spranger and Dr. Tobias Schulz, LL.M. (Edinburgh) discussed the recent development in the field of Biobanking Legislation.
Although a specific legislation on Biobanking does not exist yet in Germany, the speakers presented in the first part of the workshop the existing guidelines, available ISO certifications and affecting regulations that are currently on place.
“Technical legislation is extremely difficult, especially because the subject is often very dynamic, as for example the biobanking topic”
Moreover, based on the “Deutsche Regulierungsphilosophie” the -hopefully- upcoming legislation will be very complex and rich in gaps, and therefore providing workload for the legal counterparts.
In the more practical part of the workshop, the legal experts talked about biobanking definition, informed consent, biobanking owner vs biobanking holder, benefits sharing and usage of old probes. As expected attention was put also on the current hot topic GDPR. The new General Data Protection Regulation -which entered into force on May 25 has obviously direct implications for the existing biobanks.
The participants used the occasion to ask practical questions, to share their doubts and address the controversial points in the different regulations.
About BioRN Cluster
BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe. The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and global helathcare companies such as AbbVie, Boehringer Ingelheim, Johnson & Johnson, Merck, Roche, und Sanofi-Aventis, and about 80 small and medium-sized biotech enterprises. Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations. In terms of the use of clusters for the internationalization of companies, BioRN has founded, together with Leuven (Belgium), Maastricht (Netherlands) and Copenhagen (Denmark), an alliance for the enforcement of biomedical innovation in Europe, called the Health Axis Europe.
About Rittershaus Rechtsanwälte
Collaborative, professional, different: this is how Rittershaus Rechtsanwälte describes its consultancy services. Collaborative, because we don’t consider ourselves to be mere legal advisers of our clients, but their partner in all business matters. Professional, because we aim to be first class in our areas of expertise and always achieve the best possible outcome for our clients. And different, because we back everything we do with our entire personality. Because when it comes to complex and problematic situations, we realise that the law may be an important factor, but it is not the only one. And the optimal, i.e. sustainable legal solution can only be found if all factors are taken into account. In short, algorithms can never accomplish what we contribute through our individual personalities. We therefore set great store by fairness and team spirit, and we unite the get-up-and-go attitude of a start-up with ambition, tenacity and a pragmatic sense of efficiency.